Evaluation of the Role of < b > < i > BRAF < /i > < /b > V600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study

Conclusions: The somaticBRAFV600E mutation does not associate with a worse prognosis in low risk PTC and, in our settings, may not be considered an independent risk factor for disease persistence.Eur Thyroid J
Source: European Thyroid Journal - Category: Endocrinology Source Type: research